| 51 |
10350682 | BANFF: an update. | 1999 Apr |
7 |
| 52 |
10439882 | Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction. | 1999 May |
1 |
| 53 |
9504729 | The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study. | 1998 Jan |
1 |
| 54 |
9579768 | Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study. | 1998 Mar |
1 |
| 55 |
9717054 | Rationale for ACE inhibition as an anti-ischaemic therapy. | 1998 Jul |
1 |
| 56 |
9008252 | Angiotensin converting enzyme inhibition corrects Na+/H+ exchanger overactivity in essential hypertension. | 1997 Jan |
1 |
| 57 |
9049526 | Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model. | 1997 Jan |
1 |
| 58 |
9049577 | Effect of enalapril and quinapril on forearm vascular ACE in man. | 1997 |
7 |
| 59 |
9051387 | Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. | 1997 Mar |
1 |
| 60 |
9140710 | Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function. | 1997 May |
1 |
| 61 |
9364284 | Evidence of platelet activation in hypertension. | 1997 Sep |
1 |
| 62 |
8739020 | A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril. | 1996 May |
2 |
| 63 |
8743525 | Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension. | 1996 Jun |
2 |
| 64 |
8759064 | Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. | 1996 Aug 1 |
2 |
| 65 |
8894262 | Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker. | 1996 Sep-Oct |
1 |
| 66 |
8986916 | Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition. | 1996 Sep |
1 |
| 67 |
9064945 | [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure]. | 1996 Nov |
2 |
| 68 |
7576397 | Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. | 1995 Aug |
1 |
| 69 |
7712932 | [Long-term treatment with quinapril in chronic aortic and mitral insufficiency]. | 1995 Mar 31 |
2 |
| 70 |
7805197 | Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. | 1995 Jan 1 |
1 |
| 71 |
7527326 | Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. | 1994 Aug |
5 |
| 72 |
7713100 | Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany. | 1994 Dec |
2 |
| 73 |
7769502 | Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents. | 1994 |
1 |
| 74 |
7807504 | Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension. | 1994 Sep |
1 |
| 75 |
7874846 | Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. | 1994 Nov |
1 |
| 76 |
7919557 | Cough induced by quinapril with resolution after changing to fosinopril. | 1994 Jun |
4 |
| 77 |
7965273 | Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients. | 1994 Jul |
1 |
| 78 |
7965277 | Angiotensin converting enzyme inhibition and coronary artery disease. | 1994 Jul |
1 |
| 79 |
7965280 | Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation. | 1994 Jul |
1 |
| 80 |
7981011 | Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. | 1994 Aug |
1 |
| 81 |
8000584 | Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. | 1994 Sep |
1 |
| 82 |
8087269 | Quinapril therapy in patients with chronic mitral regurgitation. | 1994 May |
2 |
| 83 |
7728496 | [The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency]. | 1993 |
1 |
| 84 |
8357782 | The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention. | 1993 Apr |
2 |
| 85 |
8387427 | Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure. | 1993 |
1 |
| 86 |
8462229 | Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. | 1993 Mar |
1 |
| 87 |
1290245 | [Comparison of results of daily blood pressure self-monitoring and general practice monitoring within the scope of a study assessing treatment of hypertension with quinapril]. | 1992 |
1 |
| 88 |
1312002 | Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril. | 1992 Mar |
4 |
| 89 |
1312296 | Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management. | 1992 Apr 2 |
3 |
| 90 |
1329465 | Drug-patient interactions and their relevance in the treatment of heart failure. | 1992 Oct 8 |
2 |
| 91 |
1366232 | [Cardiovascular profile of the ACE-inhibitor Quinapril. Worshop report. Freiburg in Breisgau, 15-16 May 1992]. | 1992 |
1 |
| 92 |
1385791 | Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. | 1992 Aug |
1 |
| 93 |
1451252 | Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. | 1992 Dec |
2 |
| 94 |
1546636 | Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management. | 1992 Apr 2 |
1 |
| 95 |
1546638 | Effects of inhibitors of angiotensin-converting enzyme on regional hemodynamics. | 1992 Apr 2 |
1 |
| 96 |
1546639 | Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. | 1992 Apr 2 |
3 |
| 97 |
1575168 | Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. | 1992 May |
3 |
| 98 |
1575171 | Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril. | 1992 May |
3 |
| 99 |
1615796 | Determinants of the renal response to ACE inhibition in patients with congestive heart failure. | 1992 Jul |
1 |
| 100 |
1630680 | [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]. | 1992 Mar |
1 |